Drug Shortage Report for ZOFRAN ODT
Report ID | 168154 |
Drug Identification Number | 02239372 |
Brand name | ZOFRAN ODT |
Common or Proper name | ZOFRAN ODT TABS 4MG (1X10) |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | DORMANT |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 4MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 1 X 10 |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-09-26 |
Actual start date | 2022-10-20 |
Estimated end date | 2022-12-31 |
Actual end date | 2022-12-31 |
Shortage status | Resolved |
Updated date | 2024-03-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-03-07 | French | Compare |
v7 | 2024-03-07 | English | Compare |
v6 | 2022-10-21 | English | Compare |
v5 | 2022-10-20 | French | Compare |
v4 | 2022-10-20 | English | Compare |
v3 | 2022-09-27 | English | Compare |
v2 | 2022-08-29 | French | Compare |
v1 | 2022-08-29 | English | Compare |
Showing 1 to 8 of 8